| Patent Number |
Title Of Patent |
Date Issued |
| 7442373 |
Antibodies against protective antigen and methods of use for passive immunization and treatment |
October 28, 2008 |
| A highly efficient method for generating human antibodies using recall technology is provided. In one aspect, human antibodies which are specific to the anthrax toxin are provided. In one aspect, human peripheral blood cells that have been pre-exposed to anthrax toxin are used in the |
| 7438909 |
Immunization and treatment methods for anthrax |
October 21, 2008 |
| A highly efficient method for generating human antibodies using recall technology is provided. In one aspect, human antibodies which are specific to the anthrax toxin are provided. In one aspect, human peripheral blood cells that have been pre-exposed to anthrax toxin are used in the |
| 7419807 |
Chlamydia protein, gene sequence and uses thereof |
September 2, 2008 |
| A high molecular weight ("HMW") protein of Chlamydia, the amino acid sequence thereof, and antibodies that specifically bind the HMW protein are disclosed as well as the nucleic acid sequence encoding the same. Also disclosed are prophylactic and therapeutic compositions, comprising |
| 7341727 |
M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response c |
March 11, 2008 |
| The invention discloses the Moraxella catarrhalis outer membrane protein-106 (OMP106) polypeptide, polypeptides derived therefrom (OMP106-derived polypeptides), nucleotide sequences encoding said polypeptides, and antibodies that specifically bind the OMP106 polypeptide and/or OMP106 |
| 7311917 |
Moraxella catarrhalis protein, gene sequence and uses thereof |
December 25, 2007 |
| The invention discloses the Moraxella catarrhalis outer membrane protein polypeptide and polypeptides derived therefrom (collectively "OMP21"), nucleotide sequences encoding said OMP21, and antibodies that specifically bind OMP21. Also disclosed are pharmaceutical compositions includ |
| 7128910 |
Moraxella catarrahalis outer membrane protein-106 polypeptide, gene sequences and uses thereof |
October 31, 2006 |
| The invention discloses the Moraxella catarrhalis outer membrane protein-106 (OMP106) polypeptide, polypeptides derived therefrom (OMP106-derived polypeptides), nucleotide sequences encoding OMP106 polypeptides, and antibodies that specifically bind the OMP106 polypeptide and/or OMP1 |
